Wells Fargo & Company Lannett CO Inc Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.45 - $0.86 $2 - $5	6 Added 0.81%	747 $0
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.63 $6 - $8	-14 Reduced 1.85%	741 $0
Q2 2022 Aug 12, 2022	SELL	$0.47 - $0.87 $4,690 - $8,681	-9,979 Reduced 92.97%	755 $0
Q1 2022 May 16, 2022	BUY	$0.75 - $1.77 $7,500 - $17,700	10,000 Added 1362.4%	10,734 $8,000
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.93 $14 - $26	9 Added 1.24%	734 $1,000
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.83 $619 - $1,028	-213 Reduced 22.71%	725 $3,000
Q2 2021 Aug 16, 2021	SELL	$4.17 - $5.74 $1.01 Million - $1.39 Million	-242,642 Reduced 99.61%	938 $4,000
Q1 2021 May 13, 2021	BUY	$5.28 - $9.64 $839,266 - $1.53 Million	158,952 Added 187.82%	243,580 $1.29 Million
Q4 2020 Feb 09, 2021	SELL	$5.75 - $7.13 $58,184 - $72,148	-10,119 Reduced 10.68%	84,628 $552,000
Q3 2020 Nov 05, 2020	SELL	$4.9 - $7.12 $1.85 Million - $2.7 Million	-378,538 Reduced 79.98%	94,747 $579,000
Q2 2020 Aug 13, 2020	SELL	$6.43 - $9.86 $378,810 - $580,882	-58,913 Reduced 11.07%	473,285 $3.44 Million
Q1 2020 May 14, 2020	BUY	$6.36 - $10.05 $3.38 Million - $5.35 Million	532,198 New	532,198 $3.7 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.